MedTrace Logo

Phase I Clinical Trial in Healthy Male Volunteers

NCT03860532 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2019-03-05

No results posted yet for this study

Summary

This is a Phase I Randomized,Double-Blind,Placebo-controlled Trial in Healthy Male Voluteers To Examine the Safety,Tolerability,and Pharmacokinetics of HMPL-011 After A Single Dose.

Conditions

  • Inflammatory Bowel Diseases

Interventions

DRUG

HMPL-011 tablets

Eligible subjects will recieve 1200 mg HMPL-011 tablets under fed and diet circumstance.

DRUG

HMPL-011 capsules

Eligible subjects will recieve 1200 mg HMPL-011 capsules under fed and diet circumstance.

Sponsors & Collaborators

  • Hutchison Medipharma Limited

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2011-12-31
Completion
2011-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03860532 on ClinicalTrials.gov